Missing/wrong data?
Log in to edit
Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.
scientific article
Author/s
author: Clas Malmeström, Lars Rosengren, Anders Svenningsson, Jan Lycke
Work details
Publication date
December 8, 2010
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.